News
First randomized trial reassures on ACEIs, ARBs in COVID-19
September 2, 2020
The BRACE CORONA study found no difference in key outcomes between patients continuing versus stopping their medication.
News
Pandemic worsens disparities in GI and liver disease
September 1, 2020
Creative local solutions are needed to address screening and health care problems.
News
HOME-PE trial clarifies which pulmonary embolism patients to treat at home
September 1, 2020
“Who’s happy with the HOME-PE trial? I think everybody.” – Dr. Stavros V. Konstantinides
News
ESC’s revised NSTE-ACS guidelines embrace hsT, personalized anti-ischemia treatments
August 31, 2020
The first guideline update in 5 years for non ST-elevation ACS stresses high sensitivity troponin for diagnosis and tailored antiplatelet treatments.
News
Gut bacteria linked to cardiovascular, other health conditions
August 31, 2020
“Microbiota and their metabolites ... could serve as potential therapeutic targets for the maintenance of health and prevention and treatment of cardiovascular diseases.”
News
DAPA-CKD: SGLT2 inhibitor benefit extends to chronic kidney disease without diabetes
August 31, 2020
DAPA-CKD showed that dapagliflozin helps patients with albuminuria and declining eGFR levels whether or not they have type 2 diabetes.
News
EMPEROR-Reduced: Empagliflozin’s HFrEF benefit solidifies class effects
August 30, 2020
The 25% cut in primary endpoints among HFrEF patients on empagliflozin matched the benefit seen before from dapagliflozin in DAPA-HF.
News
Early rhythm control in AFib gains new life
August 30, 2020
EAST-AFNET 4 trial reanimates rhythm-control strategy as superior for 5-year cardiovascular outcomes.
News
Hospitalists balance work, family as pandemic boosts stress
August 28, 2020
Experts describe the emotional and psychological strain that has come from working during the pandemic.
News
Batten down the hatches for thyroid storm
August 28, 2020
“The big thing is to look for and treat the underlying precipitating event.”